Johnson & Johnson (JNJ)

$ 153.18
   
  • Change Today:
    $-0.48
  • 52 Week High: $167.70
  • 52 Week Low: $142.06
  • Currency: US Dollars
  • Shares Issued: 2,406.92m
  • Volume: 7,032,225
  • Market Cap: $368,692m
  • RiskGrade: 87
  • Beta: 0.03

Latest ShareCast News

Johnson & Johnson lifts guidance after strong first quarter

By Benjamin Chiou

Date: Tuesday 15 Apr 2025

(Sharecast News) - American healthcare and consumer products giant Johnson & Johnson hiked its annual guidance after a strong start to the year, with the company beating estimates on both the top and bottom lines.

US bankruptcy judge rejects Johnson & Johnson's $10bn settlement

By Iain Gilbert

Date: Tuesday 01 Apr 2025

(Sharecast News) - A bankruptcy judge in the US has rejected Johnson & Johnson's $10.0bn proposal to settle tens of thousands of lawsuits alleging that its baby powder and other talc products cause ovarian cancer.

Johnson & Johnson beats Q4 estimates with strong oncology sales

By Benjamin Chiou

Date: Wednesday 22 Jan 2025

(Sharecast News) - Stronger-than-expected sales of cancer drugs helped US healthcare giant Johnson & Johnson beat forecasts with its fourth-quarter results on Wednesday, with guidance for 2025 meeting analysts' expectations.

Johnson & Johnson to buy Intra-Cellular Therapie... 13-Jan-2025 ShareCast
Johnson & Johnson to buy V-Wave for up to $1.7bn 20-Aug-2024 ShareCast
Johnson & Johnson shares rise on earnings beat d... 17-Jul-2024 ShareCast
Johnson & Johnson proposes $6.5bn deal to settle... 01-May-2024 ShareCast
Jonnson & Johnson to buy Shockwave Medical for $... 05-Apr-2024 ShareCast
US close: Stocks recover from three days of losses 28-Mar-2024 ShareCast
US close: Stocks mixed ahead of key data releases 24-Jan-2024 ShareCast
Johnson & Johnson reports robust quarter, but fu... 23-Jan-2024 ShareCast
Johnson & Johnson to buy Ambrx for $2bn 08-Jan-2024 ShareCast
Johnson & Johnson ups guidance after Q3 beat 17-Oct-2023 ShareCast
Johnson & Johnson lifts guidance after beating Q... 20-Jul-2023 ShareCast
Johnson & Johnson boosts full-year guidance 24-Jan-2023 ShareCast
Johnson & Johnson to buy Abiomed in $16.6bn deal 01-Nov-2022 ShareCast
Third-quarter sales beat forecasts at Johnson & ... 18-Oct-2022 ShareCast
Johnson & Johnson to cease global production of ... 12-Aug-2022 ShareCast
Novavax Covid vaccine approved for use in the UK 03-Feb-2022 ShareCast
Johnson & Johnson to spin off consumer health bu... 12-Nov-2021 ShareCast
 

Note 1: Prices and trades are provided by Digital Look Corporate Solutions and are delayed by at least 15 minutes.

Note 2: RiskGrade figures are provided by RiskMetrics.

 

Johnson and Johnson Market Data

Currency US Dollars
Share Price $ 153.18
Change Today $ -0.48
% Change -0.31 %
52 Week High $167.70
52 Week Low $142.06
Volume 7,032,225
Shares Issued 2,406.92m
Market Cap $368,692m
Beta 0.03
RiskGrade 87

What The Brokers Say

Strong Buy 5
Buy 5
Neutral 14
Sell 0
Strong Sell 0
Total 24
buy
Broker recommendations should not be taken as investment advice, and are provided by the authorised brokers listed on this page.

Trades for 21-May-2025

Time Volume / Share Price
16:00 1,702,210 @ $153.18
15:59 200 @ $153.07
15:59 274 @ $153.08
15:59 100 @ $153.07
15:59 147 @ $153.07

Top of Page